news
AbbVie completes acquisition of Pharmacyclics
26 May 2015 | By Victoria White
AbbVie has completed the acquisition of Pharmacyclics, enhancing AbbVie's scientific and commercial presence in the haematological oncology market...
List view / Grid view
Mergers & Acquisitions
news
Sartorius Stedim Biotech acquires UK-based CRO, BioOutsource
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.
news
Abbott commences tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022
16 December 2014 | By Abbott
Abbott announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"), has commenced a tender offer (the "U.S. Notes Offer"), in which it is offering to purchase for cash any and all of the outstanding $300 million aggregate principal amount of 5.125% Senior Notes due…
news
Abbott completes acquisition of Veropharm
15 December 2014 | By Abbott
Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer...
news
Pharmaceutical industry feeling force of tax inversion legislation, says GlobalData Analyst
24 October 2014 | By GlobalData
The recent termination of AbbVie’s deal to acquire Shire makes this pharmaceuticals’ first major casualty of new US tax inversion legislation, and has jolted the industry out of its reverie, according to an analyst with research and consulting firm GlobalData.
news
Abbott completes acquisition of CFR Pharmaceuticals
29 September 2014 | By Abbott
Abbott has acquired control of CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding the company's presence in fast-growing markets...
news
Expiration of the U.S. Tender Offer for CFR Pharmaceuticals S.A.
24 September 2014 | By Abbott
Abbott announced the expiration of the tender offer for the purchase from U.S. holders of the ordinary shares of CFR Pharmaceuticals S.A., a Chilean corporation...
news
Thermo Fisher Scientific to acquire Life Technologies Corporation
Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, and Life Technologies Corporation (NASDAQ: LIFE), a leading life sciences company, have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the…
news
Metrohm and FOSS enter strategic alliance
Metrohm and FOSS have entered into a strategic alliance strengthening the two companies’ leading positions in their respective key markets. In this strategic alliance, Metrohm will become the sole global distributor of FOSS NIR instruments for the chemical, petrochemical, pharmaceutical, and environmental sectors.
news
Corning to acquire majority of BD Discovery Labware
Corning Incorporated (NYSE: GLW) announced today that it has reached a definitive agreement with BD (Becton, Dickinson and Company) (NYSE:BDX) to acquire the majority of its Discovery Labware unit for approximately $730 million in cash. The acquisition is expected to be completed later this year, subject to customary closing conditions,…
news
Corning to acquire Plaslab S.A.S.
Corning Incorporated (NYSE:GLW) announced today that it has reached an agreement with the shareholders of Plaslab S.A.S. to acquire all outstanding shares of the company. Assuming certain closing conditions are met, the acquisition is expected to be completed in the fourth quarter of 2010.
